Scienture Holdings, Inc. announced entering into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Securities Purchase Agreement
The agreement involves the purchase of 3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
The offering is expected to generate approximately $3.9 million before deducting expenses.
Closing Date
The offering is set to close on August 15, 2025, subject to customary conditions.
- The securities purchase agreement marks a significant financial transaction for Scienture Holdings, Inc.
- The offering price and the number of shares indicate a strategic move to raise capital for the company's operations and growth.
The agreement and offering provide insight into Scienture Holdings, Inc.'s financial activities and strategic initiatives to enhance shareholder value and support its pharmaceutical operations.